Evolution of the Average Target: Lundbeck

Evolution of the Average Target - H. Lundbeck A/S

Evolution of the Target Price: Lundbeck

Evolution of the Target Price - Lundbeck

Changes in Analyst Recommendations: Lundbeck

6.YGcWkw0SWcrIdjZ_zDZuAGfU2shWmxNsshyVUPhMfyA.MAMl3TgiOJKPEXg-iUQ3QyXkm70B63sm7UXcM6E6LFQDLW-rX1cUm_k9bw~774bab925a32835febdad7b90973f7f5
09-30 H Lundbeck: Bold moves, blind spots Alphavalue
09-25 Danske Bank raises its price target for Lundbeck to 58 Danish kroner (57), reiterates buy - BN FW
09-21 UBS upgrades Lundbeck to buy (neutral), price target 52 Danish kroner (45) FW
09-15 Deutsche Bank still sees pressure on Lundbeck, cuts to sell FW
09-15 Deutsche Bank downgrades Lundbeck to sell (hold), target price 36 Danish kroner (40) FW
09-08 Barclays raises Lundbeck price target to 50 Danish kroner (48), reiterates equal weight - BN FW
08-24 Deutsche Bank sees higher costs for Lundbeck in the second half FW
08-20 Cancer vaccines finally garner the spotlight Alphavalue
08-20 UBS raises Lundbeck price target to 45 Danish kroner (44), reiterates neutral FW
08-19 H Lundbeck: Q2 beat, but pipeline execution remains non-negotiable Alphavalue
08-17 Lundbeck expected to report DKK 1,945m in adjusted EBITDA, consensus FW
07-17 Barclays raises price target for Lundbeck to 48 Danish kroner (45), reiterates equal weight - BN FW
07-14 Where would AI lead Pharma in the long run? Alphavalue
07-13 Danske Bank raises Lundbeck price target to 57 Danish kroner (55), reiterates buy - BN FW
06-18 Nordea raises target price for Lundbeck to DKK60 (57), reiterates buy rating FW
05-13 H Lundbeck: Strong Q1, but long-term growth uncertainty hovers over valuation Alphavalue
05-13 Nordea raises Lundbeck price target to DKK 57 (55), reiterates Buy FW
05-13 DNB Carnegie raises Lundbeck price target to DKK 54 (53), reiterates Buy FW
04-28 SEB raises Lundbeck price target to DKK 46 (43), reiterates Hold FW
04-27 UBS raises Lundbeck price target to DKK 44 (42), reiterates Neutral FW
03-23 H. Lundbeck Price Target Down as AlphaValue/Baader Europe Expects Patent Expirations to Weigh on Growth MT
03-20 H Lundbeck: Markets need more proof of growth promise Alphavalue
03-05 Nordea Resumes Coverage of Lundbeck With Buy Rating – Too Cheap to Ignore FW
03-05 Nordea Resumes Coverage of Lundbeck with Buy Rating and Price Target of 55 Danish Kroner FW
03-02 Jefferies Upgrades Lundbeck to Hold (Underperform), Sets Price Target at 39 Danish Kroner FW

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+14.8%
+9.76%
+5.1%
+10.16%
+7.39%
+7.01%
+32.09%
-2.92%
+10%
Average +10.38%
Weighted average by Cap. +10.94%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
45.08DKK
Average target price
49.19DKK
Spread / Average Target
+9.12%
High Price Target
65.00DKK
Spread / Highest target
+44.19%
Low Price Target
34.00DKK
Spread / Lowest Target
-24.58%

Analyst Consensus Detail

Analyst consensus - Lundbeck

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Lundbeck
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Lundbeck